Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Embecta Corp before investing.

In this article, we go over a few key elements for understanding Embecta Corp’s stock price such as:

• Embecta Corp’s current stock price and volume
• Why Embecta Corp’s stock price changed recently
• Upgrades and downgrades for EMBC from analysts
• EMBC’s stock price momentum as measured by its relative strength

About Embecta Corp (EMBC)

Before we jump into Embecta Corp’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Embecta Corp. is a global diabetes care company. It is focused on providing solutions to people living with diabetes. It has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It has clearance from the FDA for its proprietary disposable insulin delivery system, which is indicated for adults who require insulin to manage diabetes, including both type 1 (T1D) and type 2 (T2D).

Want to learn more about Embecta Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Embecta Corp.

Embecta Corp’s Stock Price as of Market Close

As of September 05, 2024, 4:00 PM, CST, Embecta Corp’s stock price was $15.13.

Embecta Corp is down 7.97% from its previous closing price of $16.44.

During the last market session, Embecta Corp’s stock traded between $16.18 and $16.68. Currently, there are 57.77 million shares of Embecta Corp stock available for purchase.

Embecta Corp’s price-earnings (P/E) ratio is currently at 13.6, which is low compared to the Medical Equipment, Supplies & Distribution industry median of 40.2. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Embecta Corp Stock Price History

Embecta Corp’s (EMBC) price is currently down 7.41% so far this month.

During the month of September, Embecta Corp’s stock price has reached a high of $17.05 and a low of $15.07.

Over the last year, Embecta Corp has hit prices as high as $19.79 and as low as $9.93. Year to date, Embecta Corp’s stock is down 40.17%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Embecta Corp Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 04, 2024, there were 4 analysts who downgraded Embecta Corp’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Embecta Corp’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Embecta Corp’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Embecta Corp’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Embecta Corp (EMBC) by visiting AAII Stock Evaluator.

Relative Price Strength of Embecta Corp

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 04, 2024, Embecta Corp has a weighted four-quarter relative price strength of 0.95%, which translates to a Momentum Score of 67 and is considered to be Strong.

Want to learn more about how Embecta Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Embecta Corp Stock Price: Bottom Line

As of September 5, 2024, Embecta Corp’s stock price is $15.13, which is down 7.97% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Embecta Corp stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.